Medical Writing Services
Scientifically accurate, regulatory-compliant protocols, clinical study reports, and submission documents — written for the agency they are going to, delivered on time.
Versed Team
Coverage
Documents
Delivery
Writing That Moves Submissions Forward
Every study lives or dies by its documents. A protocol that anticipates regulator questions, a CSR that presents results with clarity, a dossier section that reads exactly the way the reviewing agency expects — that is the difference between a smooth approval and months of queries.
Our medical writing team specializes in BA/BE and clinical trial documentation, is well-versed in ICH E6 (R3), FDA, and EMA requirements, and works directly with sponsors to develop customized protocols and reports — with a firm commitment to on-time delivery, even under tight timelines, without compromising accuracy.
Documents We Deliver
Six document families covering the entire journey from protocol concept to published manuscript.
Protocols & Investigator Brochures
Study protocols that align with regulatory expectations, and IBs that communicate key study information clearly to investigators.
Clinical Study Reports (CSRs)
Expertly structured reports that meet regulatory requirements and present study results in a clear, defensible format.
Regulatory Submission Documents
From IND applications to NDA submissions — every document type in the approval journey, prepared to agency standards.
Patient Information Leaflets
Easy-to-understand patient materials that keep participants well informed about the treatments they receive.
Manuscripts for Publication
Peer-reviewed journal and conference manuscripts — scientifically accurate and formatted to publication guidelines.
Medical Affairs Documents
Therapeutic area overviews, clinical evidence summaries, and educational materials for medical affairs teams.
Documentation & Data Operations
Our writing and data teams work alongside the clinical and bioanalytical units — the people who write your documents sit next to the people who ran the study.
Which Document, Which Guideline, When?
A quick map of the core regulatory documents, the guideline that governs each, and where it fits in the development journey.
| Document | Governing Standard | When It Is Needed |
|---|---|---|
| Study Protocol | ICH E6 (R3) GCP | Before study start — defines design, endpoints, and conduct |
| Investigator Brochure | ICH E6 (R3) | Before and during trials — briefs investigators on the product |
| Clinical Study Report | ICH E3 | After study completion — presents methods and results for review |
| IND / NDA Documents | FDA / agency formats | At submission milestones across the approval journey |
| Patient Information Leaflet | Agency labelling rules | With product registration — informs patients clearly |
| Journal Manuscript | Journal / ICMJE guidelines | After results — publication and scientific communication |
Explore Specific Writing Services
Dedicated pages for our highest-demand documents — clinical study reports and study protocols.
Written to the Standard That Reviews It
A document meant for the FDA is not the same document meant for the EMA. Our writers tailor structure, language, and emphasis to the specific agency reviewing your submission.
Precision Writing, Backed by Real Study Teams
- Writers experienced across BA/BE and clinical trial documentation
- Deliverables tailored to the target regulatory agency
- ICH E6 (R3), FDA, and EMA aligned from the first draft
- On-time delivery, even on tight submission timelines
- Direct collaboration with sponsors on every document
- Backed by in-house clinical, PK, and biostatistics teams
Medical Writing — Frequently Asked Questions
1. What documents does your medical writing team prepare?
2. Which regulatory guidelines do your writers follow?
3. What is a clinical study report (CSR)?
4. Can you deliver documents on tight timelines?
5. Do you support journal publications?
Explore Our Other Clinical Research Services
One research partner from first protocol draft to final approval — every service under one roof.
BA/BE Studies
Bioavailability & bioequivalence studies with LC-MS/MS bioanalysis for regulated markets.
Patient-Based Clinical Trials
Phase I–IV trial management with a pan-India investigator and site network.
Regulatory Affairs
Submission strategy and lifecycle support across US, Europe, Asia, and Brazil.
Have a Deadline Coming Up?
Send us the document type and the agency it is going to — we will come back with a scope, timeline, and quote.